LumiraDx Limited (LMDXF)

Market Cap	3.59M
Revenue (ttm)	126.52M
Net Income (ttm)	-338.04M
Shares Out	358.83M
EPS (ttm)	-1.07
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	24,835
Open	0.0001
Previous Close	0.0010
Day's Range	0.0001 - 0.0100
52-Week Range	n/a
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 8, 2024

About LumiraDx

LumiraDx Limited operates as a point of care diagnostics company. The company focuses on transforming community-based healthcare by providing critical diagnostic information to healthcare providers. It manufactures and commercializes a diagnostic platform that supports various tests with lab comparable performance at the point of care. The company has tests on the market and in development covering infectious diseases, cardiovascular diseases, diabetes, and coagulation disorders, as well as a portfolio of COVID-19 testing solutions. Its diagnos...

• Industry: Diagnostics & Research
• Sector: Healthcare
• CEO: Veronique Ameye
• Employees: 1,210
• Stock Exchange: OTCMKTS
• Ticker Symbol: LMDXF

Financial Performance

In 2022, LumiraDx's revenue was $254.48 million, a decrease of -39.62% compared to the previous year's $421.43 million. Losses were -$447.79 million, 343.7% more than in 2021.